Phathom Pharmaceuticals, Inc.PHATNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank14
3Y CAGR-5.8%
5Y CAGR-14.7%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-5.8%/yr
vs +264.6%/yr prior
5Y CAGR
-14.7%/yr
Recent acceleration
Acceleration
-270.4pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $129.97M | -56.3% |
| 2024 | $297.26M | -22.1% |
| 2023 | $381.39M | +145.5% |
| 2022 | $155.38M | -15.2% |
| 2021 | $183.26M | -36.3% |
| 2020 | $287.50M | +17.9% |
| 2019 | $243.76M | +27632.1% |
| 2018 | $879000.00 | - |